Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis

ConclusionsAll patients had a rapid improvement in systemic inflammation, cardiac function, and arrhythmic burden with anti-IL1 therapy, indicating that anakinra may be an effective treatment in chronic active idiopathic myocarditis, refractory to standard treatment.
Source: Internal and Emergency Medicine - Category: Emergency Medicine Source Type: research